Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 06:00PM GMT
Release Date Price: $12.96 (+0.78%)
Federica Lussana;JPMorgan;Analyst

Good morning, everyone. My name is Federica Lussana. I'm part of the healthcare investment banking team at JPMorgan. It is my pleasure to introduce you to our next presenting company, Kura Oncology. The speaker is Troy Wilson, President and Chief Executive Officer.

As a kind reminder, after this session, we have a breakout session in room Sussex. Thank you, everybody.

Troy Edward Wilson
Kura Oncology, Inc. - Chairman, CEO & President

Good morning, and thank you for the introduction. I am Troy Wilson. I'm the President and Chief Executive Officer of Kura Oncology. And I'd like to start by thanking JPMorgan for the gracious invitation to let us attend the conference and give you an update on the progress that we've been making at the company.

Just to start off, I'll just refer you to our forward-looking statement and our filings, both on our website and on the SEC's website, for additional information about Kura. So Kura is really capitalizing on the advances in the discovery

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot